Atlas Trials

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Clinical trial NCT04191486 · COMPLETED

Trial details

NCT number
NCT04191486
Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mild Cognitive Impairment
Start date
2019-12-24
Primary completion
2023-02-22
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.